MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 25 - per page Next page
Order by
A number of specific PPLs, a group of prenylflavanone compounds, some novel, were isolated, identified and tested at as low as 0.04 μg/mL to be able to increase survival of neural stem cells, to promote neuronal growth with lengthening of neurite More
Colorless molecule that will bind and enhance the differential surface charge on protein complexes: The molecule has been demonstrated to work as well as Coomassie blue but will not interfere in gel assays critical for most investigations. More
Biomarker and possible therapeutic target for a variety of neurodegenerative diseases More
These analogs may increase water solubility and bioavailability for improved therapeutic formulation and utility More
Findings indicate that activation of Nurr1 may be therapeutically useful for Parkinson's disease patients; therefore, the mice would be useful in Parkinson's disease research. More
a sustained-release pharmaceutical delivery system for the administration of an antioxidant drug to a patient in need of such drug, wherein said delivery system comprises said drug in combination with a polymeric matrix, said matrix comprising a... More
Researchers have developed a nucleic acid plasmid construction capable of undergoing transfection into dopaminergic neurons. More
Effective treatment options for diseases such as Alzheimer's, Parkinson's, and cataracts are needed. This new group of compounds have the potential to treat disorders caused by oxidative stress by functioning as antioxidants and metal chelators. More
New surrogate biomarker to monitor the progression of HIV infection and other conditions and diseases associated with immune system activation More
A method to promote stem cell survival and proliferation by manipulating the phosphorylation state, a key protein in these processes More
Displaying 1..10 of 25 - per page Next page
Order by

Your selection

Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Parkinson's disease del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us